Patent · US Active

Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions

US9410156B2 · kind B2 · utility

3Cited by
30References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2013
Grant dateAug 9, 2016
Priority date
Expiry dateMar 28, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aptamers that bind PDGF and aptamers that bind VEGF are provided. In addition, aptamer constructs comprising a PDGF aptamer and a VEGF aptamer are provided. Pharmaceutical compositions comprising the aptamers and aptamer constructs are provided, as well as methods of treating conditions using the aptamers and aptamer constructs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.